These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7978716)

  • 1. End-stage renal disease attributable to diabetes mellitus.
    Perneger TV; Brancati FL; Whelton PK; Klag MJ
    Ann Intern Med; 1994 Dec; 121(12):912-8. PubMed ID: 7978716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minority advantage in diabetic end-stage renal disease survival on hemodialysis: due to different proportions of diabetic type?
    Medina RA; Pugh JA; Monterrosa A; Cornell J
    Am J Kidney Dis; 1996 Aug; 28(2):226-34. PubMed ID: 8768918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the rate of renal function decline in non-insulin-dependent diabetes mellitus.
    Garza R; Medina R; Basu S; Pugh JA
    Am J Nephrol; 1997; 17(1):59-67. PubMed ID: 9057955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.
    Humphrey LL; Ballard DJ; Frohnert PP; Chu CP; O'Fallon WM; Palumbo PJ
    Ann Intern Med; 1989 Nov; 111(10):788-96. PubMed ID: 2817626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy.
    Pugh JA; Medina R; Ramirez M
    Diabetologia; 1993 Oct; 36(10):1094-8. PubMed ID: 8243860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess incidence of treatment of end-stage renal disease in Mexican Americans.
    Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M
    Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA; Ng MC; Palmer ND; Keaton JM; Larsen CP; Hicks PJ; ; Langefeld CD; Freedman BI; Bowden DW
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1434-40. PubMed ID: 24948143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians.
    Nelson RG; Newman JM; Knowler WC; Sievers ML; Kunzelman CL; Pettitt DJ; Moffett CD; Teutsch SM; Bennett PH
    Diabetologia; 1988 Oct; 31(10):730-6. PubMed ID: 3240833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
    Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
    Bruce R; Williams L; Cundy T
    Aust N Z J Med; 1994 Aug; 24(4):390-5. PubMed ID: 7980236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom.
    Burden AC; McNally PG; Feehally J; Walls J
    Diabet Med; 1992; 9(7):641-5. PubMed ID: 1511571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
    Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
    Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.